80 participants
A Phase Ib/II Trial to Evaluate the Safety and Efficacy of QL1706 in Patients With Advanced Hepatocellular Carcinoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2022-11-02
- Start Date:
- 2021-07-01
- Completion:
- 2023-12-30
Conditions
- Advanced Liver Cancer
Interventions
- DRUG
No Results Yet